A data-driven drug repositioning framework discovered a potential therapeutic agent targeting COVID-19

Yiyue Ge(Jiangsu Provincial Center for Disease Control and Prevention), Jianyang Zeng(Westlake University), Ze‐Hong Miao(Shanghai Institute of Materia Medica), Hantao Shu(Tsinghua University), Hui Yang(Silexon AI Technology (China)), Xiaolong Feng(Tongji Hospital), Li Zeng(Convalife (China)), Suling Huang(Shanghai Institute of Materia Medica), Tingzhong Tian(Tsinghua University), Yipin Lei(Tsinghua University), Haidong Tang(Changsha University of Science and Technology), Lili Cheng(Tsinghua University), Xiao Liang(Convalife (China)), Lunbiao Cui(Jiangsu Provincial Center for Disease Control and Prevention), Hainian Zeng(Silexon AI Technology (China)), Dan Zhao(Tsinghua University), Enming Yuan(Tsinghua University), Lixiang Hong(Tsinghua University), Fengcai Zhu(Jiangsu Provincial Center for Disease Control and Prevention), Ziyuan Jiang(Tsinghua University), Chunhao Yang(Chinese Academy of Sciences), Fang Wan(Translational Therapeutics (United States)), Shuya Li(Tsinghua University), Xiaokun Shen(Convalife (China)), Ligong Chen(Sichuan University), Ying Chi(Chinese Academy of Medical Sciences & Peking Union Medical College), Jingxin Li(University of Pennsylvania), Xiling Guo(Jiangsu Provincial Center for Disease Control and Prevention), Nian Wu(Jinan University)
bioRxiv (Cold Spring Harbor Laboratory)
March 12, 2020
Cited by 168


Related Papers